These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8128170)

  • 21. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflux oesophagitis and oesophageal transit: evidence for a primary oesophageal motor disorder.
    Eriksen CA; Sadek SA; Cranford C; Sutton D; Kennedy N; Cuschieri A
    Gut; 1988 Apr; 29(4):448-52. PubMed ID: 3371713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis.
    Hendel L
    Aliment Pharmacol Ther; 1991 Oct; 5(5):471-80. PubMed ID: 1793779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.
    Dehn TC; Shepherd HA; Colin-Jones D; Kettlewell MG; Carroll NJ
    Gut; 1990 May; 31(5):509-13. PubMed ID: 2190864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oesophageal acid clearance in patients with severe reflux oesophagitis.
    Barham CP; Gotley DC; Mills A; Alderson D
    Br J Surg; 1995 Mar; 82(3):333-7. PubMed ID: 7796001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflux patterns and related oesophageal motor activity in gastro-oesophageal reflux disease.
    Kruse-Andersen S; Wallin L; Madsen T
    Gut; 1990 Jun; 31(6):633-8. PubMed ID: 2379866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of ranitidine in the treatment of esophagitis caused by gastro-esophageal acid reflux].
    Nervi M; Conte M; Buttitta F; Spisni R
    Minerva Dietol Gastroenterol; 1989; 35(3):195-9. PubMed ID: 2689913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate analysis of pathophysiological factors in reflux oesophagitis.
    Cadiot G; Bruhat A; Rigaud D; Coste T; Vuagnat A; Benyedder Y; Vallot T; Le Guludec D; Mignon M
    Gut; 1997 Feb; 40(2):167-74. PubMed ID: 9071926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H; Klein M; Bauer A; Arnold R
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal pH monitoring and reflux oesophagitis in irritable infants.
    Vandenplas Y; Badriul H; Verghote M; Hauser B; Kaufman L
    Eur J Pediatr; 2004 Jun; 163(6):300-4. PubMed ID: 15346910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oesophagitis and pH of refluxate: an experimental and clinical study.
    Zaninotto G; Di Mario F; Costantini M; Baffa R; Germanà B; Dal Santo PL; Rugge M; Bolzan M; Naccarato R; Ancona E
    Br J Surg; 1992 Feb; 79(2):161-4. PubMed ID: 1555066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oesophageal motor events at the occurrence of acid reflux and during endogenous acid exposure in healthy subjects and in patients with oesophagitis.
    Baldi F; Ferrarini F; Balestra R; Borioni D; Longanesi A; Miglioli M; Barbara L
    Gut; 1985 Apr; 26(4):336-41. PubMed ID: 3979906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
    Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.